{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T00:49:49Z","timestamp":1790642989255,"version":"4.1.0"},"reference-count":113,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100001205","name":"F. M. Kirby Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100001205","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Paul and Evanina Bell Mackall Foundation Trust"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","surveyophthalmol.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Survey of Ophthalmology"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1016\/j.survophthal.2015.08.005","type":"journal-article","created":{"date-parts":[[2015,8,29]],"date-time":"2015-08-29T21:05:09Z","timestamp":1440882309000},"page":"33-50","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"title":["Retinal abnormalities in \u03b2-thalassemia major"],"prefix":"10.1016","volume":"61","author":[{"given":"Devang L.","family":"Bhoiwala","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5864-0607","authenticated-orcid":false,"given":"Joshua L.","family":"Dunaief","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.survophthal.2015.08.005_bib1","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1046\/j.1365-2362.2002.01033.x","article-title":"Elastic tissue abnormalities in inherited haemolytic syndromes","volume":"32","author":"Aessopos","year":"2002","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.survophthal.2015.08.005_bib2","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1182\/blood.V99.1.30","article-title":"Elastic tissue abnormalities resembling pseudoxanthoma elasticum in beta thalassemia and the sickling syndromes","volume":"99","author":"Aessopos","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.survophthal.2015.08.005_bib3","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s12185-007-0014-y","article-title":"Loss of vision associated with angioid streaks in beta-thalassemia intermedia","volume":"87","author":"Aessopos","year":"2008","journal-title":"Int J Hematol"},{"key":"10.1016\/j.survophthal.2015.08.005_bib4","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1002\/ajh.2830410304","article-title":"Pseudoxanthoma elasticum-like skin lesions and angioid streaks in beta-thalassemia","volume":"41","author":"Aessopos","year":"1992","journal-title":"Am J Hematol"},{"key":"10.1016\/j.survophthal.2015.08.005_bib5","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/S0002-9394(14)73300-8","article-title":"Angioid streaks in homozygous beta thalassemia","volume":"108","author":"Aessopos","year":"1989","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.survophthal.2015.08.005_bib6","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1007\/BF02032108","article-title":"Pseudoxanthoma elasticum and angioid streaks in two cases of beta-thalassaemia","volume":"8","author":"Aesopos","year":"1989","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.survophthal.2015.08.005_bib7","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1001\/archopht.1983.01040020051008","article-title":"Retinal abnormalities associated with anemia","volume":"101","author":"Aisen","year":"1983","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.survophthal.2015.08.005_bib8","doi-asserted-by":"crossref","first-page":"22","DOI":"10.3109\/08820538.2013.839811","article-title":"Retinal fiber layer thickness in children with thalessemia major and iron deficiency anemia","volume":"29","author":"Aksoy","year":"2014","journal-title":"Semin Ophthalmol"},{"key":"10.1016\/j.survophthal.2015.08.005_bib9","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1136\/bjo.68.12.873","article-title":"Ocular changes in patients undergoing long-term desferrioxamine treatment","volume":"68","author":"Arden","year":"1984","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.survophthal.2015.08.005_bib10","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1002\/ajh.20090","article-title":"Gregory Evans K: Desferrioxamine related maculopathy: a case report","volume":"76","author":"Arora","year":"2004","journal-title":"Am J Hematol"},{"key":"10.1016\/j.survophthal.2015.08.005_bib11","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1097\/IAE.0b013e3181679f67","article-title":"Deferoxamine-related ocular toxicity: incidence and outcome in a pediatric population","volume":"28","author":"Baath","year":"2008","journal-title":"Retina"},{"key":"10.1016\/j.survophthal.2015.08.005_bib12","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1034\/j.1600-0609.2003.00073.x","article-title":"Bull's eye maculopathy with deferoxamine","volume":"70","author":"Bansal","year":"2003","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.survophthal.2015.08.005_bib13","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.ophtha.2013.10.016","article-title":"The spectrum of ocular alterations in patients with beta-thalassemia syndromes suggests a pathology similar to pseudoxanthoma elasticum","volume":"121","author":"Barteselli","year":"2014","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2015.08.005_bib14","first-page":"345","article-title":"Cerebral and ocular toxicity induced by desferrioxamine","volume":"56","author":"Blake","year":"1985","journal-title":"Q\u00a0J Med"},{"key":"10.1016\/j.survophthal.2015.08.005_bib15","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1056\/NEJM200011303432216","article-title":"Hepatic iron concentration and total body iron stores in thalassemia major","volume":"343","author":"Bonkovsky","year":"2000","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.survophthal.2015.08.005_bib16","first-page":"463","article-title":"[Gronblad-Strandberg syndrome: association of angioid streaks and an elastic pseudoxanthoma (apropos of a case in a 20-year-old young woman)]","volume":"89","author":"Bordat","year":"1989","journal-title":"Bull Soc Ophtalmol Fr"},{"key":"10.1016\/j.survophthal.2015.08.005_bib17","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1056\/NEJM199409013310902","article-title":"Efficacy of deferoxamine in preventing complications of iron overload in patients with thalassemia major","volume":"331","author":"Brittenham","year":"1994","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.survophthal.2015.08.005_bib18","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/GIM.0b013e3181cd68ed","article-title":"Beta-thalassemia","volume":"12","author":"Cao","year":"2010","journal-title":"Genet Med"},{"key":"10.1016\/j.survophthal.2015.08.005_bib19","series-title":"Guidelines for the Clinical Management of Thalassaemia","author":"Cappellini","year":"2008"},{"key":"10.1016\/j.survophthal.2015.08.005_bib20","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1159\/000186094","article-title":"Ocular and auditory toxicity in hemodialyzed patients receiving desferrioxamine","volume":"56","author":"Cases","year":"1990","journal-title":"Nephron"},{"key":"10.1016\/j.survophthal.2015.08.005_bib21","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1159\/000207831","article-title":"A\u00a0new approach to the diagnosis of beta-thalassaemia","volume":"58","author":"Chalevelakis","year":"1977","journal-title":"Acta Haematol"},{"key":"10.1016\/j.survophthal.2015.08.005_bib22","doi-asserted-by":"crossref","first-page":"4961","DOI":"10.1016\/j.bmcl.2015.03.012","article-title":"Small cyclic agonists of iron regulatory hormone hepcidin","volume":"25","author":"Chua","year":"2015","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.survophthal.2015.08.005_bib23","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1046\/j.1365-2362.2002.01032.x","article-title":"Cardiovascular involvement in thalassaemic patients with pseudoxanthoma elasticum-like skin lesions: a long-term follow-up study","volume":"32","author":"Cianciulli","year":"2002","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.survophthal.2015.08.005_bib24","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/S0022-3476(05)80556-6","article-title":"Vision and hearing during deferoxamine therapy","volume":"117","author":"Cohen","year":"1990","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.survophthal.2015.08.005_bib25","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.parkreldis.2014.03.002","article-title":"Efficacy and safety of deferiprone for the treatment of pantothenate kinase-associated neurodegeneration (PKAN) and neurodegeneration with brain iron accumulation (NBIA): results from a four years follow-up","volume":"20","author":"Cossu","year":"2014","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.survophthal.2015.08.005_bib26","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s00277-005-0075-z","article-title":"Combined therapy with desferrioxamine and deferiprone in beta thalassemia major patients with transfusional iron overload","volume":"85","author":"Daar","year":"2006","journal-title":"Ann Hematol"},{"key":"10.1016\/j.survophthal.2015.08.005_bib27","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0140-6736(83)90170-8","article-title":"Ocular toxicity of high-dose intravenous desferrioxamine","volume":"2","author":"Davies","year":"1983","journal-title":"Lancet"},{"key":"10.1016\/j.survophthal.2015.08.005_bib28","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1136\/adc.63.3.250","article-title":"Depletion of trace elements and acute ocular toxicity induced by desferrioxamine in patients with thalassaemia","volume":"63","author":"De Virgiliis","year":"1988","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.survophthal.2015.08.005_bib29","first-page":"718","article-title":"In\u00a0vivo fluorescence of the ocular fundus exhibits retinal pigment epithelium lipofuscin characteristics","volume":"36","author":"Delori","year":"1995","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.survophthal.2015.08.005_bib30","first-page":"38","article-title":"[Ocular findings in Desferal therapy]","volume":"92","author":"Dennerlein","year":"1995","journal-title":"Ophthalmologe"},{"key":"10.1016\/j.survophthal.2015.08.005_bib31","doi-asserted-by":"crossref","first-page":"4660","DOI":"10.1167\/iovs.06-0568","article-title":"Iron induced oxidative damage as a potential factor in age-related macular degeneration: the Cogan Lecture","volume":"47","author":"Dunaief","year":"2006","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.survophthal.2015.08.005_bib32","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1001\/archopht.120.11.1435","article-title":"The role of apoptosis in age-related macular degeneration","volume":"120","author":"Dunaief","year":"2002","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.survophthal.2015.08.005_bib33","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1016\/j.ophtha.2004.12.029","article-title":"Macular degeneration in a patient with aceruloplasminemia, a disease associated with retinal iron overload","volume":"112","author":"Dunaief","year":"2005","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2015.08.005_bib34","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/ICB.0b013e3181f0470f","article-title":"Intravitreal bevacizumab (avastin) for choroidal neovascularization associated with deferoxamine retinopathy","volume":"5","author":"Duval","year":"2011","journal-title":"Retin Cases Brief Rep"},{"key":"10.1016\/j.survophthal.2015.08.005_bib35","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.2147\/OPTH.S35627","article-title":"New optical coherence tomography fundus findings in a case of beta-thalassemia","volume":"6","author":"Eleftheriadou","year":"2012","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.survophthal.2015.08.005_bib36","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/0042-6989(95)00100-E","article-title":"Infrared imaging of sub-retinal structures in the human ocular fundus","volume":"36","author":"Elsner","year":"1996","journal-title":"Vis Res"},{"key":"10.1016\/j.survophthal.2015.08.005_bib37","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.survophthal.2008.12.006","article-title":"Pseudoxanthoma elasticum: genetics, clinical manifestations and therapeutic approaches","volume":"54","author":"Finger","year":"2009","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.survophthal.2015.08.005_bib38","first-page":"357","article-title":"Ocular changes in B-thalassemia","volume":"30","author":"Gaba","year":"1998","journal-title":"Ann Ophthalmol"},{"key":"10.1016\/j.survophthal.2015.08.005_bib39","first-page":"795","article-title":"Deferiprone in the treatment of transfusion-dependent thalassemia: a review and perspective","volume":"3","author":"Galanello","year":"2007","journal-title":"Ther Clin Risk Manag"},{"key":"10.1016\/j.survophthal.2015.08.005_bib40","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1373\/clinchem.2014.229179","article-title":"Hepcidin and the global burden of iron deficiency","volume":"61","author":"Ganz","year":"2015","journal-title":"Clin Chem"},{"key":"10.1016\/j.survophthal.2015.08.005_bib41","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/0002-9394(89)90864-7","article-title":"Ocular abnormalities in patients with beta thalassemia","volume":"108","author":"Gartaganis","year":"1989","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.survophthal.2015.08.005_bib42","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1097\/00006982-200310000-00029","article-title":"\u201cComet\u201d lesion: an ocular sign of pseudoxanthoma elasticum","volume":"23","author":"Gass","year":"2003","journal-title":"Retina"},{"key":"10.1016\/j.survophthal.2015.08.005_bib43","first-page":"669","article-title":"Enhancement of retinal recovery by conjugated deferoxamine after ischemia-reperfusion","volume":"35","author":"Gehlbach","year":"1994","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.survophthal.2015.08.005_bib44","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1097\/ICB.0000000000000059","article-title":"Multimodal imaging in a case of deferoxamine-induced maculopathy","volume":"8","author":"Gelman","year":"2014","journal-title":"Retin Cases Brief Rep"},{"key":"10.1016\/j.survophthal.2015.08.005_bib45","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s10633-010-9236-z","article-title":"Macular vitelliform lesion in desferrioxamine-related retinopathy","volume":"121","author":"Genead","year":"2010","journal-title":"Doc Ophthalmol"},{"key":"10.1016\/j.survophthal.2015.08.005_bib46","first-page":"81","article-title":"Angioid streaks, clinical course, complications, and current therapeutic management","volume":"5","author":"Georgalas","year":"2009","journal-title":"Ther Clin Risk Manag"},{"key":"10.1016\/j.survophthal.2015.08.005_bib47","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1136\/bjo.67.1.29","article-title":"Angioid streaks in a case of beta thalassaemia major","volume":"67","author":"Gibson","year":"1983","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.survophthal.2015.08.005_bib48","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1097\/00006982-200406000-00024","article-title":"Bilateral vitelliform maculopathy and deferoxamine toxicity","volume":"24","author":"Gonzales","year":"2004","journal-title":"Retina"},{"key":"10.1016\/j.survophthal.2015.08.005_bib49","doi-asserted-by":"crossref","first-page":"2728","DOI":"10.1167\/iovs.07-1472","article-title":"Ceruloplasmin\/hephaestin knockout mice model morphologic and molecular features of AMD","volume":"49","author":"Hadziahmetovic","year":"2008","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.survophthal.2015.08.005_bib50","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1167\/tvst.1.3.2","article-title":"The oral iron chelator deferiprone protects against retinal degeneration induced through diverse mechanisms","volume":"1","author":"Hadziahmetovic","year":"2012","journal-title":"Transl Vis Sci Technol"},{"key":"10.1016\/j.survophthal.2015.08.005_bib51","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1167\/iovs.10-6113","article-title":"Age-dependent retinal iron accumulation and degeneration in hepcidin knockout mice","volume":"52","author":"Hadziahmetovic","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.survophthal.2015.08.005_bib52","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1167\/iovs.10-6207","article-title":"The oral iron chelator deferiprone protects against iron overload-induced retinal degeneration","volume":"52","author":"Hadziahmetovic","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.survophthal.2015.08.005_bib53","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1136\/bjo.59.5.267","article-title":"Angioid streaks and traumatic ruptures of Bruch's membrane","volume":"59","author":"Hagedoorn","year":"1975","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.survophthal.2015.08.005_bib54","first-page":"598","article-title":"Immunolocalization and regulation of iron handling proteins ferritin and ferroportin in the retina","volume":"10","author":"Hahn","year":"2004","journal-title":"Mol Vis"},{"key":"10.1016\/j.survophthal.2015.08.005_bib55","doi-asserted-by":"crossref","first-page":"13850","DOI":"10.1073\/pnas.0405146101","article-title":"Disruption of ceruloplasmin and hephaestin in mice causes retinal iron overload and retinal degeneration with features of age-related macular degeneration","volume":"101","author":"Hahn","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.survophthal.2015.08.005_bib56","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/S0161-6420(01)00947-2","article-title":"The expanded clinical spectrum of deferoxamine retinopathy","volume":"109","author":"Haimovici","year":"2002","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2015.08.005_bib57","first-page":"74","article-title":"Groenblad Strandberg syndrome\u2013a case report","volume":"39","author":"Harikrishnan","year":"1991","journal-title":"Indian J Ophthalmol"},{"key":"10.1016\/j.survophthal.2015.08.005_bib58","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.preteyeres.2007.07.004","article-title":"Iron homeostasis and toxicity in retinal degeneration","volume":"26","author":"He","year":"2007","journal-title":"Prog Retin Eye Res"},{"key":"10.1016\/j.survophthal.2015.08.005_bib59","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s10633-005-1336-9","article-title":"EOG as a monitor of desferrioxamine retinal toxicity","volume":"109","author":"Hidajat","year":"2004","journal-title":"Doc Ophthalmol"},{"key":"10.1016\/j.survophthal.2015.08.005_bib60","first-page":"1051","article-title":"Fundus autofluorescence and development of geographic atrophy in age-related macular degeneration","volume":"42","author":"Holz","year":"2001","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.survophthal.2015.08.005_bib61","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.1167\/iovs.05-1027","article-title":"Predictive value of fundus autofluorescence for development of geographic atrophy in age-related macular degeneration","volume":"47","author":"Hwang","year":"2006","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.survophthal.2015.08.005_bib62","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1038\/sj.eye.6700352","article-title":"Quantitative evaluation of the retinal venous tortuosity in chronic anaemic patients affected by beta-thalassaemia major","volume":"17","author":"Incorvaia","year":"2003","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.survophthal.2015.08.005_bib63","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1023\/A:1001728512515","article-title":"Rod and rod mediated function in patients with beta-thalassemia major","volume":"96","author":"Jiang","year":"1998","journal-title":"Doc Ophthalmol"},{"key":"10.1016\/j.survophthal.2015.08.005_bib64","first-page":"3634","article-title":"Linsenmeier RA: Effects of hypoxemia on the a- and b-waves of the electroretinogram in the cat retina","volume":"41","author":"Kang Derwent","year":"2000","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.survophthal.2015.08.005_bib65","doi-asserted-by":"crossref","first-page":"293","DOI":"10.3109\/08880018809037369","article-title":"Deferoxamine (Desferal)-induced ocular toxicity","volume":"5","author":"Kaplinsky","year":"1988","journal-title":"Pediatr Hematol Oncol"},{"key":"10.1016\/j.survophthal.2015.08.005_bib66","doi-asserted-by":"crossref","first-page":"3556","DOI":"10.1167\/iovs.06-0122","article-title":"Near-infrared autofluorescence imaging of the fundus: visualization of ocular melanin","volume":"47","author":"Keilhauer","year":"2006","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.survophthal.2015.08.005_bib67","doi-asserted-by":"crossref","first-page":"3531","DOI":"10.1167\/iovs.05-1290","article-title":"Fundus autofluorescence and mfERG for early detection of retinal alterations in patients using chloroquine\/hydroxychloroquine","volume":"47","author":"Kellner","year":"2006","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.survophthal.2015.08.005_bib68","doi-asserted-by":"crossref","first-page":"e141770","DOI":"10.1001\/jamaophthalmol.2014.1770","article-title":"Angioid streaks in association with sickle thalassemia trait","volume":"133","author":"Ketner","year":"2015","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.survophthal.2015.08.005_bib69","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1136\/bjo.72.4.303","article-title":"Angioid streaks in beta thalassaemia minor","volume":"72","author":"Kinsella","year":"1988","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.survophthal.2015.08.005_bib70","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S0161-6420(84)34267-1","article-title":"Deferoxamine (Desferal)-induced toxic retinal pigmentary degeneration and presumed optic neuropathy","volume":"91","author":"Lakhanpal","year":"1984","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2015.08.005_bib71","doi-asserted-by":"crossref","first-page":"289","DOI":"10.3389\/fgene.2012.00289","article-title":"The molecular and physiological roles of ABCC6: more than meets the eye","volume":"3","author":"Le Saux","year":"2012","journal-title":"Front Genet"},{"key":"10.1016\/j.survophthal.2015.08.005_bib72","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1001\/archopht.125.11.1581","article-title":"Effects of desferoxamine on retinal and visual function","volume":"125","author":"Lu","year":"2007","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.survophthal.2015.08.005_bib73","first-page":"131","article-title":"Toxic effects of high-dose deferoxamine treatment in patients with iron overload: an electrophysiological study of cerebral and visual function","volume":"76","author":"Marciani","year":"1991","journal-title":"Haematologica"},{"key":"10.1016\/j.survophthal.2015.08.005_bib74","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.ajpath.2010.10.004","article-title":"A\u00a0mouse model of beta-thalassemia shows a liver-specific down-regulation of Abcc6 expression","volume":"178","author":"Martin","year":"2011","journal-title":"Am J Pathol"},{"key":"10.1016\/j.survophthal.2015.08.005_bib75","series-title":"Studies on retinal and choroidal disorders","first-page":"259","article-title":"The Role of Iron in Retinal Diseases","author":"Mehta","year":"2012"},{"key":"10.1016\/j.survophthal.2015.08.005_bib76","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/S0002-9394(14)72914-9","article-title":"Deferoxamine-associated retinopathy after subcutaneous injection","volume":"118","author":"Mehta","year":"1994","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.survophthal.2015.08.005_bib77","doi-asserted-by":"crossref","first-page":"12413","DOI":"10.1073\/pnas.0503460102","article-title":"RPE65 is the isomerohydrolase in the retinoid visual cycle","volume":"102","author":"Moiseyev","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.survophthal.2015.08.005_bib78","doi-asserted-by":"crossref","first-page":"583","DOI":"10.3324\/haematol.10842","article-title":"Liver iron concentrations and urinary hepcidin in beta-thalassemia","volume":"92","author":"Origa","year":"2007","journal-title":"Haematologica"},{"key":"10.1016\/j.survophthal.2015.08.005_bib79","first-page":"153","article-title":"Ocular and auditory toxicity of long-term, high-dose subcutaneous deferoxamine therapy","volume":"20","author":"Orton","year":"1985","journal-title":"Can J Ophthalmol"},{"key":"10.1016\/j.survophthal.2015.08.005_bib80","doi-asserted-by":"crossref","first-page":"5053","DOI":"10.1016\/S0021-9258(18)99669-9","article-title":"Kinetic studies of ferrous ion oxidation with crystalline human ferroxidase (ceruloplasmin)","volume":"241","author":"Osaki","year":"1966","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.survophthal.2015.08.005_bib81","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1136\/bjo.73.1.42","article-title":"Ocular toxicity of desferrioxamine\u2014an example of copper promoted auto-oxidative damage?","volume":"73","author":"Pall","year":"1989","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.survophthal.2015.08.005_bib82","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1097\/ICB.0b013e3181af7b44","article-title":"Optical coherence tomography findings in deferasirox-related maculopathy","volume":"4","author":"Pan","year":"2010","journal-title":"Retin Cases Brief Rep"},{"key":"10.1016\/j.survophthal.2015.08.005_bib83","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1182\/blood-2012-12-471441","article-title":"Transfusion suppresses erythropoiesis and increases hepcidin in adult patients with beta-thalassemia major: a longitudinal study","volume":"122","author":"Pasricha","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.survophthal.2015.08.005_bib84","doi-asserted-by":"crossref","first-page":"5382","DOI":"10.1167\/iovs.14-14179","article-title":"Monomethylfumarate induces gamma-globin expression and fetal hemoglobin production in cultured human retinal pigment epithelial (RPE) and erythroid cells, and in intact retina","volume":"55","author":"Promsote","year":"2014","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.survophthal.2015.08.005_bib85","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1136\/bjo.70.5.373","article-title":"Ocular toxicity of desferrioxamine: light microscopic histochemical and ultrastructural findings","volume":"70","author":"Rahi","year":"1986","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.survophthal.2015.08.005_bib86","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1093\/ndt\/5.11.945","article-title":"Acute visual disorders in patients on regular dialysis given desferrioxamine as a test","volume":"5","author":"Ravelli","year":"1990","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.survophthal.2015.08.005_bib87","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1097\/01.ICB.0000279640.76453.eb","article-title":"Fundus autofluorescence in retinopathy caused by deferoxamine toxicity","volume":"1","author":"Reddy","year":"2007","journal-title":"Retin Cases Brief Rep"},{"key":"10.1016\/j.survophthal.2015.08.005_bib88","first-page":"23","article-title":"Ocular involvement correlated with age in patients affected by major and intermedia beta-thalassemia treated or not with desferrioxamine","volume":"16","author":"Rinaldi","year":"1993","journal-title":"Metab Pediatr Syst Ophthalmol"},{"key":"10.1016\/j.survophthal.2015.08.005_bib89","series-title":"Retina","author":"Ryan","year":"2013"},{"key":"10.1016\/j.survophthal.2015.08.005_bib90","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1002\/ajh.23934","article-title":"Combination therapy with a Tmprss6 RNAi-therapeutic and the oral iron chelator deferiprone additively diminishes secondary iron overload in a mouse model of beta-thalassemia intermedia","volume":"90","author":"Schmidt","year":"2015","journal-title":"Am J Hematol"},{"key":"10.1016\/j.survophthal.2015.08.005_bib91","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1182\/blood-2012-09-453977","article-title":"An RNAi therapeutic targeting Tmprss6 decreases iron overload in Hfe(-\/-) mice and ameliorates anemia and iron overload in murine beta-thalassemia intermedia","volume":"121","author":"Schmidt","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.survophthal.2015.08.005_bib92","doi-asserted-by":"crossref","first-page":"315","DOI":"10.4103\/0301-4738.98714","article-title":"Desferrioxamine-related ocular toxicity: a case report","volume":"60","author":"Simon","year":"2012","journal-title":"Indian J Ophthalmol"},{"key":"10.1016\/j.survophthal.2015.08.005_bib93","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3389\/fnagi.2013.00024","article-title":"Retinal iron homeostasis in health and disease","volume":"5","author":"Song","year":"2013","journal-title":"Front Aging Neurosci"},{"key":"10.1016\/j.survophthal.2015.08.005_bib94","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.freeradbiomed.2012.04.020","article-title":"Systemic administration of the iron chelator deferiprone protects against light-induced photoreceptor degeneration in the mouse retina","volume":"53","author":"Song","year":"2012","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.survophthal.2015.08.005_bib95","doi-asserted-by":"crossref","first-page":"4525","DOI":"10.1167\/iovs.14-14568","article-title":"The oral iron chelator deferiprone protects against systemic iron overload-induced retinal degeneration in hepcidin knockout mice","volume":"55","author":"Song","year":"2014","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.survophthal.2015.08.005_bib96","first-page":"23","article-title":"Ocular findings in beta-thalassemia","volume":"13","author":"Sorcinelli","year":"1990","journal-title":"Metab Pediatr Syst Ophthalmol"},{"key":"10.1016\/j.survophthal.2015.08.005_bib97","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1055\/s-2008-1035273","article-title":"[Ocular side effects of deferoxamine therapy in aplastic anemia with transfusion-induced hemochromatosis]","volume":"209","author":"Spraul","year":"1996","journal-title":"Klin Monbl Augenheilkd"},{"key":"10.1016\/j.survophthal.2015.08.005_bib98","first-page":"114","article-title":"Fundus autofluorescence in age-related macular disease imaged with a laser scanning ophthalmoscope","volume":"113","author":"Struharova","year":"2012","journal-title":"Bratisl Lek Listy"},{"key":"10.1016\/j.survophthal.2015.08.005_bib99","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.ajo.2006.04.030","article-title":"Ocular findings among thalassemia patients","volume":"142","author":"Taher","year":"2006","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.survophthal.2015.08.005_bib100","doi-asserted-by":"crossref","first-page":"125","DOI":"10.4103\/0301-4738.60083","article-title":"Multiple transfused thalassemia major: ocular manifestations in a hospital-based population","volume":"58","author":"Taneja","year":"2010","journal-title":"Indian J Ophthalmol"},{"key":"10.1016\/j.survophthal.2015.08.005_bib101","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1167\/iovs.07-1372","article-title":"Synthesis and secretion of hemoglobin by retinal pigment epithelium","volume":"50","author":"Tezel","year":"2009","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.survophthal.2015.08.005_bib102","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/ICB.0000000000000013","article-title":"Spectral domain optical coherence tomography findings in early deferoxamine maculopathy: report of two cases","volume":"8","author":"Van Bol","year":"2014","journal-title":"Retin Cases Brief Rep"},{"key":"10.1016\/j.survophthal.2015.08.005_bib103","doi-asserted-by":"crossref","first-page":"203","DOI":"10.3109\/08820539809056054","article-title":"Scanning laser ophthalmoscope microperimetry","volume":"13","author":"Varano","year":"1998","journal-title":"Semin Ophthalmol"},{"key":"10.1016\/j.survophthal.2015.08.005_bib104","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1016\/j.ophtha.2012.01.039","article-title":"Abnormal fundus autofluorescence results of patients in long-term treatment\u00a0with deferoxamine","volume":"119","author":"Viola","year":"2012","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2015.08.005_bib105","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1097\/IAE.0000000000000073","article-title":"Multimodal imaging in deferoxamine retinopathy","volume":"34","author":"Viola","year":"2014","journal-title":"Retina"},{"key":"10.1016\/j.survophthal.2015.08.005_bib106","first-page":"478","article-title":"Fundus autofluorescence in age-related macular disease imaged with a laser scanning ophthalmoscope","volume":"38","author":"von Ruckmann","year":"1997","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.survophthal.2015.08.005_bib107","series-title":"Thalassemias: eLS","author":"Weatherall","year":"2001"},{"key":"10.1016\/j.survophthal.2015.08.005_bib108","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/35066048","article-title":"Phenotype-genotype relationships in monogenic disease: lessons from the thalassaemias","volume":"2","author":"Weatherall","year":"2001","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.survophthal.2015.08.005_bib109","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1016\/j.ajpath.2011.12.041","article-title":"Ferroxidase hephaestin's cell-autonomous role in the retinal pigment epithelium","volume":"180","author":"Wolkow","year":"2012","journal-title":"Am J Pathol"},{"key":"10.1016\/j.survophthal.2015.08.005_bib110","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1097\/IAE.0b013e318074c290","article-title":"Iron toxicity as a potential factor in AMD","volume":"27","author":"Wong","year":"2007","journal-title":"Retina"},{"key":"10.1016\/j.survophthal.2015.08.005_bib111","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/1471-2415-14-88","article-title":"Deferoxamine retinopathy: spectral domain-optical coherence tomography findings","volume":"14","author":"Wu","year":"2014","journal-title":"BMC Ophthalmol"},{"key":"10.1016\/j.survophthal.2015.08.005_bib112","doi-asserted-by":"crossref","first-page":"2862","DOI":"10.1016\/j.ajpath.2014.07.008","article-title":"A\u00a0high serum iron level causes\u00a0mouse retinal iron accumulation despite an intact blood-retinal barrier","volume":"184","author":"Zhao","year":"2014","journal-title":"Am J Pathol"},{"key":"10.1016\/j.survophthal.2015.08.005_bib113","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1172\/JCI44303","article-title":"mTOR-mediated dedifferentiation of the retinal pigment epithelium initiates photoreceptor degeneration in mice","volume":"121","author":"Zhao","year":"2011","journal-title":"J\u00a0Clin Invest"}],"container-title":["Survey of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039625715001514?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039625715001514?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T11:41:56Z","timestamp":1758541316000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039625715001514"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1]]},"references-count":113,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,1]]}},"alternative-id":["S0039625715001514"],"URL":"https:\/\/doi.org\/10.1016\/j.survophthal.2015.08.005","relation":{},"ISSN":["0039-6257"],"issn-type":[{"value":"0039-6257","type":"print"}],"subject":[],"published":{"date-parts":[[2016,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Retinal abnormalities in \u03b2-thalassemia major","name":"articletitle","label":"Article Title"},{"value":"Survey of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.survophthal.2015.08.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}